INDEPENDENT PERSPECTIVES ON WHOLE-PERSON HEALTHSearch the Journal ↗
Wholistic Health Journal
NEWS, PROVIDERS, AND DESTINATIONS FOR WHOLE-PERSON HEALTH
Sections & searchAll news & research
News
Health & Wellness TopicsFind a ProviderFeatured Providers by StateWellness DestinationsGet MatchedFor ProvidersSearch

NEWS BRIEF · Research journal

Rare GLP1R variants diminish the weight loss effect of semaglutide but not of tirzepatide

Source: Nature Metabolism · Source publication date:

From the report

Nature Metabolism, Published online: 13 November 2026; doi:10.1038/s42255-026-01661-2In a large, real-world genomic study, rare damaging variants in the gene encoding the glucagon-like peptide 1 (GLP1) receptor blunted weight loss in people taking semaglutide but had no significant effect on weight loss with tirzepatide, a drug that also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor.

Continue reading

All news →